In GDM, key components of the insulin signaling pathway such as phosphorylated IRS1 (p-IRS1) and AKT (p-AKT) are upregulated, while levels of suppressor of cytokine signaling 3 (SOCS3) are decreased [81]. The gene discussed is INS; the disease is gestational diabetes.